Deutsche Bank Lowers PT on Medicis Pharmaceuticals to $41

Symbols: MRX
Share

Deutsche Bank has lowered the price target on Medicis Pharmaceuticals (NYSE: MRX) from $44 to $41 and maintains its Buy rating.


 
 
< Previous
Goldman Sachs Raises PT on Google to $685
Next >
Piper Jaffray Lowers PT on Cavium to $16
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust